Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in TRDA held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | BAKER BROS. ADVISORS LP | 5.1M | $64.0M | 0.0% | 13.067% | 0.37% |
| 2 | 5AM Venture Management, LLC | 4.1M | $51.2M | 0.0% | 10.449% | 14.21% |
| 3 | BlackRock, Inc. | 2.4M | $29.8M | +9.8% | 6.076% | 0.00% |
| 4 | TCG Crossover Management, LLC | 2.3M | $28.9M | +9.5% | 5.893% | 0.83% |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 1.3M | $15.9M | β | 3.235% | 0.00% |
| 6 | WELLINGTON MANAGEMENT GROUP LLP | 1.0M | $13.1M | -0.9% | 2.666% | 0.00% |
| 7 | StepStone Group LP | 761K | $9.6M | 0.0% | 1.961% | 4.63% |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 667K | $8.4M | +4.3% | 1.719% | 0.00% |
| 9 | STATE STREET CORP | 534K | $6.7M | +4.9% | 1.375% | 0.00% |
| 10 | MILLENNIUM MANAGEMENT LLC | 519K | $6.6M | +4.3% | 1.338% | 0.00% |
| 11 | Jones Hill Capital LP | 374K | $4.7M | β | 0.963% | 1.01% |
| 12 | JACOBS LEVY EQUITY MANAGEMENT, INC | 334K | $4.2M | -8.0% | 0.860% | 0.02% |
| 13 | DIMENSIONAL FUND ADVISORS LP | 324K | $4.1M | +18.7% | 0.836% | 0.00% |
| 14 | NORTHERN TRUST CORP | 235K | $3.0M | +3.8% | 0.605% | 0.00% |
| 15 | VANGUARD PORTFOLIO MANAGEMENT LLC | 220K | $2.8M | β | 0.568% | 0.00% |
| 16 | Woodline Partners LP | 216K | $2.7M | +52.0% | 0.556% | 0.01% |
| 17 | CITADEL ADVISORS LLC | 215K | $2.7M | -26.6% | 0.554% | 0.00% |
| 18 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 215K | $2.7M | -2.9% | 0.553% | 0.00% |
| 19 | GOLDMAN SACHS GROUP INC | 213K | $2.7M | +3.7% | 0.548% | 0.00% |
| 20 | Lynx1 Capital Management LP | 212K | $2.7M | +309.5% | 0.545% | 0.42% |
| 21 | Longaeva Partners L.P. | 205K | $2.6M | β | 0.528% | 0.14% |
| 22 | RENAISSANCE TECHNOLOGIES LLC | 202K | $2.6M | -20.0% | 0.521% | 0.00% |
| 23 | BNP PARIBAS ARBITRAGE, SA | 181K | $2.3M | +0.1% | 0.467% | 0.00% |
| 24 | MORGAN STANLEY | 176K | $2.2M | -32.3% | 0.454% | 0.00% |
| 25 | Nuveen, LLC | 176K | $2.2M | +211.3% | 0.453% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). β% of Fundβ shows how much of that investorβs total 13F portfolio is invested in TRDA β a direct measure of their conviction.
Filings activity in TRDA during Q1 2026, grouped by how each filer changed its position.
Institutions that opened a new TRDA position in Q1 2026
Institutions that fully closed their TRDA position in Q1 2026
8 quarters of 13F filings Β· Ξ columns show change vs prior quarter
| Quarter | Inst. Holders | Ξ Holders | Ownership % | Ξ Ownership | Total 13F Value | Ξ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 117 | +5.4% | 123.85% | +26.88 pp | $311M | +28% |
| Q4 2025 | 111 | 2.6% | 96.97% | +31.60 pp | $243M | +48% |
| Q3 2025 | 114 | +6.5% | 65.37% | 6.76 pp | $164M | 9.4% |
| Q2 2025 | 107 | 1.8% | 72.13% | 26.85 pp | $181M | 27% |
| Q1 2025 | 109 | +7.9% | 98.98% | 90.34 pp | $248M | 48% |
| Q4 2024 | 101 | +4.1% | 189.32% | +19.03 pp | $475M | +11% |
| Q3 2024 | 97 | +17% | 170.29% | +20.75 pp | $427M | +14% |
| Q2 2024 | 83 | β | 149.54% | β | $375M | β |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Ξ columns compare to the immediately prior filed quarter.
Latest Form 4 transactions by company officers and directors. Insider buys are widely viewed as the highest-conviction signal because executives are risking personal capital.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| May 20, 2026 | Zeiher Bernhardt G | Buy | 5K | $5.86 | $29K |
Quick answers to the most common questions about buying TRDA stock.
Based on Q1 2026 13F filings, institutional ownership of Entrada Therapeutics, Inc. stands at 123.8%, held across 117 reporting institutions.
BAKER BROS. ADVISORS LP is the largest reported institutional holder of TRDA, with approximately 5,072,730 shares worth $0.06B as of Q1 2026.
Yes β 3 widely-followed marquee investors appear among the top 25 institutional holders of TRDA, including MILLENNIUM MANAGEMENT LLC, CITADEL ADVISORS LLC, RENAISSANCE TECHNOLOGIES LLC.
Our composite Smart Money Score for TRDA is 74 out of 100 (Bullish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
21 institutions opened new positions in TRDA during Q1 2026, while 15 fully exited. 76 added to existing positions and 18 trimmed.
TRDA institutional ownership rose by 26.88 percentage points quarter-over-quarter, with a net change of +6 holders.
The top 10 institutions account for 75.4% of all reported 13F value in TRDA, and the top 25 account for 89.6%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Entrada Therapeutics, Inc. (TRDA) Institutional Ownership